<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04142736</url>
  </required_header>
  <id_info>
    <org_study_id>2019/68-UCI-HUSC</org_study_id>
    <nct_id>NCT04142736</nct_id>
  </id_info>
  <brief_title>PRone positioN in Patients With spontanEous ventiLation and Acute Hypoxemic respIratory FailurE</brief_title>
  <acronym>PRONELIFE</acronym>
  <official_title>PRone positioN in Patients With spontanEous ventiLation and Acute Hypoxemic respIratory FailurE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed randomized controlled trial aims at comparing the application of the prone&#xD;
      position in spontaneously breathing patients with acute hypoxemic respiratory failure from&#xD;
      any cause versus standard treatment on the rate of invasive mechanical ventilation or&#xD;
      all-cause of mortality. The secondary endpoints will include time to tracheal intubation and&#xD;
      effects of awake proning on the oxygenation parameters, dyspnea sensation, complications, and&#xD;
      tolerance. Other endpoints are ventilation free-days at 28 days, duration of invasive&#xD;
      ventilation, length of ICU and hospital stay, ICU and hospital mortality, and 28, 60, and&#xD;
      90-day mortality.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators intend to recruit acute hypoxemic respiratory failure patients with a&#xD;
      respiratory rate of more than 25 breaths per minute, SpO2 &lt; 94% and FiO2 of at least 40% or&#xD;
      more by either Venturi facemask, HFNC, or NIV/CPAP and, absence of decompensated respiratory&#xD;
      acidosis during two years. Currently, the investigators expect about 35 centers to&#xD;
      participate in the trial.&#xD;
&#xD;
      Demographic data and clinical characteristics on screened patients, regardless of enrolment&#xD;
      criteria match, will be recorded (registry). The investigators will randomize 650 patients&#xD;
      admitted to the participating centers' intensive care units and expect each participating&#xD;
      center to randomize at least 25 patients who meet all inclusion criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite endpoint comprising the rate of tracheal intubation or all-cause of mortality during the first fourteen days of enrolment.</measure>
    <time_frame>14 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality at day 14</measure>
    <time_frame>14 days</time_frame>
    <description>Effect of prone position on mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubation among survivors at day 24</measure>
    <time_frame>24 days</time_frame>
    <description>Effect of prone position on the rate of intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects on oxygenation defined by the SpO2</measure>
    <time_frame>4 hours</time_frame>
    <description>Effects of prone position on oxygenation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days under the oxygen support device</measure>
    <time_frame>28 days</time_frame>
    <description>Days under the oxygen support device (HFNC, NIV, non-rebreather mask, Venturi mask) The VAS is a straight horizontal line of fixed length. The ends are defined as the extreme limits of the parameter to be measured (symptom,pain,health) orientated from the left (worst) to the right (best).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea</measure>
    <time_frame>4 hours</time_frame>
    <description>Effects of prone position on dyspnea, defined according modified Borg dyspnea scale.&#xD;
This is a scale rates the difficulty of breathing. It starts at number 0 where dyspnea is causing no difficulty at all and progresses through to number 10 where dyspnea is maximal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to tracheal intubation</measure>
    <time_frame>14 days</time_frame>
    <description>Effects of prone position on timing for tracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complications related to prone position</measure>
    <time_frame>4 hours</time_frame>
    <description>Effects of prone position on adverse effects such Oxygen desaturations (SpO2 &lt;90%)&#xD;
Episodes of hemodynamic instability (BPsys &lt; 90mmHg or BPsys drop &gt; 10mmHg if BPsys &lt; 90 before the maneuver)&#xD;
Need of orotracheal intubation&#xD;
Cardiac arrest&#xD;
Displacement of the non-invasive respiratory support device&#xD;
Removal of central venous line, if documented&#xD;
Displacement of an arterial line, if documented&#xD;
Displacement of a urinary catheter, if documented</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>4 hours</time_frame>
    <description>Effects of prone position of respiratory rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of invasive mechanical ventilation</measure>
    <time_frame>90 days</time_frame>
    <description>Duration of invasive mechanical ventilation in those patients who required intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilation-free days (VFD) at 28 days from ICU admission,</measure>
    <time_frame>28 days</time_frame>
    <description>Ventilation-free days (VFD) at 28 days from ICU admission, defined as the number of days alive and free from IMV during the first 28 days from start of IMV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-free days and hospital-free days</measure>
    <time_frame>90 days</time_frame>
    <description>ICU-free days and hospital-free days at day 90</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 and 90 days</time_frame>
    <description>Mortality at day 28 and day 90</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">650</enrollment>
  <condition>Respiratory Failure With Hypoxia</condition>
  <condition>Respiratory Failure Without Hypercapnia</condition>
  <arm_group>
    <arm_group_label>Prone position</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with acute hypoxemic respiratory failure from any cause</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supine position</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with acute hypoxemic respiratory failure from any cause</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prone Position</intervention_name>
    <description>The best-fitting and most-tolerated oxygen interface will be used in the prone position--this could be different from patient to patient, and different from what is used in the supine position, and could differ between patients but also institutions (i.e., depending on the availability of masks with or without a reservoir bag and with or without the Venturi system, HFNO, CPAP or NIV). The patient will be placed in the prone position for at least 2 hours, which may be prolonged if the patient is comfortable or interrupted if the patient presents any criteria for prone position discontinuation. After the prone position period, the patient will be rotated to the semi-recumbent supine position for at least 2 hours and a maximum of 4 hours. This 2-hour time frame will depend on nursing availability, need for hygiene, complementary explorations, or diet.</description>
    <arm_group_label>Prone position</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  &gt;18 years&#xD;
&#xD;
          -  Acute respiratory failure from any cause&#xD;
&#xD;
          -  Admitted to a participating ICU&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Presence of any contraindication to prone position (APPENDIX i)&#xD;
&#xD;
          -  The patient meets the criteria for intubation (see item 7.2.3)&#xD;
&#xD;
          -  Participating in other interventional studies with the same primary outcome&#xD;
&#xD;
          -  Receiving comfort care only&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Artigas, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>I3PT Institut d'Investigació i Innovació Parc Taulí</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luis Morales-Quinteros, MD</last_name>
    <phone>+ 34 648493973</phone>
    <email>luchomq2077@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gemma Goma, RN</last_name>
    <phone>+34 639 34 35 11</phone>
    <email>gemmagomafernandez@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>I3PT Institut d'Investigació i Innovació Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Luis Morales-Quinteros, MD</last_name>
      <phone>+34 648493973</phone>
      <email>luchomq2077@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Gemma Goma, RN</last_name>
      <phone>+34 639 34 35 11</phone>
      <email>gemmagomafernandez@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, Devaquet J, Nseir S, Razazi K, Mira JP, Argaud L, Chakarian JC, Ricard JD, Wittebole X, Chevalier S, Herbland A, Fartoukh M, Constantin JM, Tonnelier JM, Pierrot M, Mathonnet A, Béduneau G, Delétage-Métreau C, Richard JC, Brochard L, Robert R; FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015 Jun 4;372(23):2185-96. doi: 10.1056/NEJMoa1503326. Epub 2015 May 17.</citation>
    <PMID>25981908</PMID>
  </reference>
  <reference>
    <citation>Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20.</citation>
    <PMID>23688302</PMID>
  </reference>
  <reference>
    <citation>Scaravilli V, Grasselli G, Castagna L, Zanella A, Isgrò S, Lucchini A, Patroniti N, Bellani G, Pesenti A. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: A retrospective study. J Crit Care. 2015 Dec;30(6):1390-4. doi: 10.1016/j.jcrc.2015.07.008. Epub 2015 Jul 16.</citation>
    <PMID>26271685</PMID>
  </reference>
  <reference>
    <citation>Riera J, Pérez P, Cortés J, Roca O, Masclans JR, Rello J. Effect of high-flow nasal cannula and body position on end-expiratory lung volume: a cohort study using electrical impedance tomography. Respir Care. 2013 Apr;58(4):589-96. doi: 10.4187/respcare.02086.</citation>
    <PMID>23050520</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Luis Morales</investigator_full_name>
    <investigator_title>Study Coordinator</investigator_title>
  </responsible_party>
  <keyword>Prone position</keyword>
  <keyword>Acute Respiratory Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified individual participant data for all primary and secondary outcome measures will be made available</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will be available within 6 months of study completion</ipd_time_frame>
    <ipd_access_criteria>Data access request will be reviewed by an External Independent Review Panel. Requestors will be required to signed a Data Access Agreement</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

